The Federal Trade Commission has found that the now-shuttered cancer testing company LabMD failed to adequately protect the personal information of nearly 10,000 patients, reversing an in-house judge’s decision in a closely watched data security case.
In an opinion written for the commission, FTC Chairwoman Edith Ramirez described LabMD’s data security practices as “unreasonable, lacking even basic precautions to protect the sensitive consumer information maintained on its computer system.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
